Published September 9, 2022
- CADTH has launched a new Post-Market Drug Evaluation Program to fill a key gap in Canada’s drug safety and effectiveness landscape.
- The cornerstone of the new program is the CoLab — an evidence generation network comprised of leading experts from across Canada in applied research, drug evaluation methodologies, and data analysis. It will answer questions from senior government decision-makers with timely and targeted evidence reviews based on real-world data.
- CADTH’s Post-Market Drug Evaluation Program will help Canada’s health systems determine if the drugs already being used in a real-world setting are safe, work as intended, and are used appropriately.